Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency

J Allergy Clin Immunol Pract. 2019 Mar;7(3):1055-1057.e2. doi: 10.1016/j.jaip.2018.10.041. Epub 2018 Nov 5.

¹ Department of Medicine, Institute of Radiology, University of Udine, Udine, Italy.
² Department of Health Sciences, Tumor Immunology Unit, University of Palermo, Palermo, Italy.
³ Department of Pathology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
⁴ Department of Pneumology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
⁵ Department of Medicine, University of Udine, Udine, Italy.
⁶ Second Unit of Internal Medicine, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy. Electronic address: decarli.marco@libero.it.

No abstract available

MeSH terms